ST. CHARLES, MEAGHAN, PHD

EDUCATION
B.A. (Psychology) 2001, Providence College
M.S. (Pharmacoepidemiology) 2005, University of Maryland
Ph.D. (Pharmacoepidemiology) 2007, University of Maryland

 

EMPLOYMENT

 

2009 - Present Associate Research Scientist, Division of Clinical and Outcomes Research (COR), Lovelace Respiratory Research Institute, North Carolina Research Campus, Kannapolis, NC
5/08 - 2009 Associate Research Scientist, Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, North Carolina Research Campus, Kannapolis, NC
2007 - 5/08 Adjunct Associate Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2007 - Present Research Scientist, IMS Health, Noblesville, IN
2006 - Present Medical Liaison, Deborah Wood Associates, Carmel, IN
Summer 2005 Pharmacoepidemiology – Intern, Merck & Co., Inc., Blue Bell, PA
2001 - 2003 Clinical Research Coordinator II, Genitourinary Oncology, Dana Farber Cancer Institute (DFCI), Boston, MA

 







 

REPRESENTATIVE PUBLICATIONS
(Published under the name M. Donovan.)

  1. Weiss, S. W. and M. Donovan: Perinatal Session at the 21st ICPE. ISPE Scribe 4th Quarter, 8(4): 5, 2005.

     

  2. Oh, W. K., C. Austin, J. Manola, D. J. George, M. Donovan, et al.: Development of an Integrated Prostate Cancer Research Information System: Prostate CRIS. Clin. Genitourinary Onc. 5: 61-66, 2006.

     

  3. Donovan, M., K. Lunney, O. Carter-Pokras and R. K. Cross: Prescribing Patterns and Awareness of Adverse Effects of Infliximab: A Health Survey of Gastroenterologists. Digestive Disease and Sciences, April 2007.

     

PRESENTATIONS
(Also presented under the name M. Donovan.)

  1. Tommasello, A. and M. Donovan: The Pharmacist’s Role in Buprenorphine Prescribing for Opiate Addiction. Poster Presentation at The Robert Wood Johnson Foundation Substance Abuse Policy Research Program, Park City, UT, December 2-4, 2003.

     

  2. Donovan, M., K. Lunney, O. Carter-Pokras and R. Cross: Infliximab Prescribing Patterns Among Gastroenterologists in Maryland and Washington D.C. Poster Presentation at University of Maryland School of Pharmacy Research Day, Baltimore, MD, 2005.

     

  3. Donovan, M., K. Lunney, O. Carter-Pokras and R. Cross: Infliximab Prescribing Patterns Among Gastroenterologists in Maryland and Washington D.C. Poster Presentation at Digestive Diseases Week, Los Angeles, CA, May 2006.

     

  4. Donovan, M.: Introduction to Statistics. Oral Presentation at Deborah Wood Associates, Carmel, IN, August 2006.

     

  5. Palmer, A. J., M. E. Minshall, W. J. Valentine, V. Foos, R. W. Baran, M. E. Donovan and C. Silberman: Long-Term Cost-Effectiveness Analysis on Actos for the USA from PROactive. Poster Presentation at 67th Annual American Diabetes Association Annual Meeting. Chicago, IL, June 22-25, 2007.

     

  6. Minshall, M. E., M. St. Charles, B. J. Pandya and R. W. Baran: The Cost-Effectiveness of Pioglitazone Compared with Sitagliptin: An Economic Evaluation Using the CORE Diabetes Model. Poster Presentation at ISPOR 10th Annual European Congress, Dublin, Ireland, October 22-23, 2007.

     

  7. Minshall, M. E., M. St. Charles, S. L. Tunis, B. J. Pandya and R. W. Baran: The Cost-Effectiveness of Pioglitazone Compared with Rosiglitazone: An Economic Evaluation Using the CORE Diabetes Model. Poster Presentation at ISPOR 10th Annual European Congress, Dublin, Ireland, October 22-23, 2007.

     

  8. Tunis, S. L., M. St. Charles, E. Pelletier and P. McEwan: The Impact of Different Resource Cost Definitions on Results, Interpretations, and Comparability of Health Economic Studies. Workshop Presentation at ISPOR 10th Annual European Congress, Dublin, Ireland, October 24, 2007.

     

  9. Minshall, M. E., M. St. Charles, B. J. Pandya and R. W. Baran: The Cost-Effectiveness of Pioglitazone Plus Glimepiride Compared with Rosiglitazone Plus Glimepiride: An Economic Evaluation Using a Previously Validated and Reliable Economic Model from a Third-Party Payer Perspective in the USA. Poster Presentation at 7th Annual Diabetes Technology Meeting, San Francisco, CA, October 25-27, 2007.

     

  10. Minshall, M. E., M. St. Charles, B. J. Pandya and R. W. Baran: Cost-Effectiveness of Pioglitazone Plus Metformin Compared with Rosiglitazone Plus Metformin: An Economic Evaluation Using a Previously Validated Economic Model from a Third-Party Payer Perspective in the USA. Poster Presentation at 7th Annual Diabetes Technology Meeting, San Francisco, CA, October 25-27, 2007.
Home    Animal Respect Code    Site Map    Employee Links    Contact
© 2008 - 2012 Lovelace Respiratory Research Institute